Need assistance?
We’re here for you

NovoCare® is here to help patients like you access and afford their medications. This site is available 24/7, and we offer live support through the phone numbers listed below.

Further down on this page, you’ll also find answers to frequently asked questions.

Need assistance?
We’re here for you

NovoCare® is here to help patients like you access and afford their medications. This site is available 24/7, and we offer live support through the phone numbers listed below.

Further down on this page, you’ll also find answers to frequently asked questions.

Diabetes

Monday-Friday, 8:00 am-11:00 pm
Saturday, 11:00 am-7:00 pm
Eastern Standard Time

Obesity

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Primary hyperoxaluria type 1 (PH1)

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Growth Hormone

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Hemophilia

Monday-Friday, 8:00 am-8:00 pm
Eastern Standard Time

Report a side effect or issue with your medication

Please submit a form online or by calling 800‑727‑6500

Frequently Asked Questions

Frequently Asked Questions 

Medicines are incredibly expensive to research and develop in general. It can take billions of dollars to bring a single safe and effective medicine to market.

Your insurance situation also factors into the price you pay for medicine. Novo Nordisk has teams of people negotiating with insurers to ensure better coverage for our products. Ultimately, though, it’s up to the insurer to decide whether to cover a product and the level of coverage. Additionally, your insurance provider will determine whether you pay a flat fee, called a “copay,” or a percentage of the total cost, called “coinsurance."

To find out if your insurance covers your medicine, make a selection below.

Diabetes medicines
Fiasp® (insulin aspart) injection 100 U/mL
Levemir® (insulin detemir) injection 100 U/mL
NovoLog® (insulin aspart) injection 100 U/mL
NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
Tresiba® (insulin degludec) injection 100 U/mL or 200 U/mL
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg
Xultophy® 100/3.6 (insulin degludec and liraglutide) injection 100 U/mL and 3.6 mg/mL

Obesity medicines
Saxenda® (liraglutide) injection 3 mg
Wegovy® (semaglutide) injection 2.4 mg

Primary hyperoxaluria type 1 (PH1) medicine
For coverage information, connect with a NovoCare® representative at 844‑906‑5099

Growth-related disorders medicines
For coverage information about Novo Nordisk growth-related disorders medicines, connect with a NovoCare® representative at 888‑668‑6444

Hemophilia and rare bleeding disorders medicines
For coverage information about Novo Nordisk hemophilia and rare bleeding disorders medicines, connect with a NovoCare® representative at 844‑668‑6732

There are limits to the ways in which Novo Nordisk can support patients with government-funded insurance.  

For patients with diabetes, please call 844-Novo4Me (844-668-6463) to discuss other options that may be available.

For patients with obesity, growth-related disorders, or hemophilia and bleeding disorders, please contact your prescription insurance provider to discuss options.

We have assistance programs and savings offers which may help reduce the cost of your insulin or provide it at no cost, depending on your situation.

If you have questions about your copay offer, please contact the following numbers for your medicine:

Diabetes medicines
Fiasp® (insulin aspart) injection 100 U/mL—833-992-3299
NovoLog® (insulin aspart) injection 100 U/mL—833-992-3299
NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL—833-992-3299
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg—877-304-6855
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg—877-304-6855
Tresiba® (insulin degludec) injection 100 U/mL or 200 U/mL—833-992-3299

Other products
ZEGALOGUE® (dasiglucagon) injection 0.6 mg/0.6 mL—833-992-3299

Obesity medicines
Wegovy® (semaglutide) injection 2.4 mg—888-793-1218

Primary hyperoxaluria type 1 (PH1) medicine
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg—844-906-5099

Growth-related disorders medicines
Norditropin® (somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens—866‑316‑2404
Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, 15 mg pens—866-316-2404

Hemophilia and rare bleeding disorders medicines
For all hemophilia and rare bleeding disorder medications, please call 844‑668‑6732

Important Safety Information for Norditropin®

Do not use Norditropin® if: 

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea
  • you have cancer or other tumors
  • you are allergic to somatropin or any of the ingredients in Norditropin®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
  • you are a child with closed bone growth plates (epiphyses)
Scroll to ISI

What is Norditropin®?

Norditropin® is a prescription medicine that contains human growth hormone and is used to treat:

  • children who are not growing because of low or no growth hormone
  • children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
  • children who have Idiopathic Short Stature (ISS)
  • children who are not growing who have Prader-Willi syndrome (PWS)
  • adults who do not make enough growth hormone
Scroll to Indication

Important Safety Information:

Do not use Norditropin® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea
  • you have cancer or other tumors
  • you are allergic to somatropin or any of the ingredients in Norditropin®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
  • you are a child with closed bone growth plates (epiphyses)

Before taking Norditropin®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
  • have had a history of problems breathing while you sleep (sleep apnea)
  • have or have had cancer or any tumor
  • have diabetes
  • are pregnant or breastfeeding, or plan to become pregnant or breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works.

How should I use Norditropin®?

  • Use Norditropin® exactly as your health care provider tells you to
  • Do not share your Norditropin® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

What are the possible side effects of Norditropin®?

Norditropin® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin
  • new or worsening high blood sugar (hyperglycemia) or diabetes
  • increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider
  • serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating
  • your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention.
  • decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness or weight loss
  • decrease in thyroid hormone levels
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis)
  • worsening of pre-existing curvature of the spine (scoliosis)
  • severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain.
  • loss of fat and tissue weakness in the area of skin you inject
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood

The most common side effects of Norditropin® include:

  • injection site reactions and rashes, and headaches

Please click here for Norditropin® Prescribing Information.

Norditropin® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information for Sogroya®

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. 
  • It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Important Safety Information

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have had cancer or any tumor
  • have diabetes
  • have adrenal gland problems
  • are taking replacement therapy with glucocorticoids
  • have thyroid gland problems
  • have liver problems
  • are a child with a history of worsening of curvature of the spine (scoliosis)
  • are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.

How should I use Sogroya®?

  • Use Sogroya® exactly as your healthcare provider tells you to
  • Use Sogroya® 1 time each week
  • If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
  • If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
  • Sogroya® pens are for use by 1 person only
  • Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
  • new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
  • increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
  • serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
  • your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
  • decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
  • worsening of curvature of the spine in children (scoliosis)
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis)
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya® Prescribing Information.

Sogroya® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.